September 20, 2017 6:16pm

Shares closed up +$1.41 or +3.22 to $45.21 while the aftermarket drops -$1.95 or -4.31%

106,32 M shares outstanding a float of 70.66 M and a BIG shirt position of 15.43 M shares and 697.62 M in cash, 10 M indebtbut 82,57 M in revenue


Juno Therapeutics Inc. (JUNO) fell after the biopharmaceutical company announced the launch of a proposed follow-on public offering worth $225 million.

Juno said it expects to grant the underwriters an option to purchase up to an additional $33.75 million of shares. The company plans on using the proceeds for … the usual, general corporate purposes and working capital, Juno said in a statement.

Morgan Stanley and J.P. Morgan are joint book runners. The stock ended the regular trading session up 3.2%.